La descarga está en progreso. Por favor, espere

La descarga está en progreso. Por favor, espere

Criterios de Clasificación del Síndrome de Ovario Poliquístico Profesor Titular: Dr. Héctor Godoy Morales Profesor Adjunto: Dr. Alfredo Ulloa Aguirre Presenta:

Presentaciones similares


Presentación del tema: "Criterios de Clasificación del Síndrome de Ovario Poliquístico Profesor Titular: Dr. Héctor Godoy Morales Profesor Adjunto: Dr. Alfredo Ulloa Aguirre Presenta:"— Transcripción de la presentación:

1 Criterios de Clasificación del Síndrome de Ovario Poliquístico Profesor Titular: Dr. Héctor Godoy Morales Profesor Adjunto: Dr. Alfredo Ulloa Aguirre Presenta: Dr. Horacio Alvarado Delgado R1BR The Rotterdam ESHRE/ASRM – Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long – term health risks related to polycystic ovary syndrome. Fertility and Sterility 81(1) 19 – 25, Jan 2004 Azziz R., Carmina E., Dewally D., et al., POSITION STATEMENT: Criteria for defining Polycystic Ovary Syndrome as a predominantly hyperandrogenyc syndrome: An Androgen Excess Society Guideline. The Journal of Clinical Endocrinology & Metabolism 91 (11): 4237 –

2 Síndrome de Ovario Poliquístico 1935 Stein yLeventhal Incremento riesgo Infertilidad DMt2 Dislipidemia Hipertensión Enfermedad Cardiovascular Azziz R., Carmina E., Dewally D., et al., POSITION STATEMENT: Criteria for defining Polycystic Ovary Syndrome as a predominantly hyperandrogenyc syndrome: An Androgen Excess Society Guideline. The Journal of Clinical Endocrinology & Metabolism 91 (11): 4237 –

3 Clasificación NIH (Abril 1990) Hiperandrogenismo o Hiperandrogenemia Oligoovulación Exclusión de otras patologías Azziz R., Carmina E., Dewally D., et al., POSITION STATEMENT: Criteria for defining Polycystic Ovary Syndrome as a predominantly hyperandrogenyc syndrome: An Androgen Excess Society Guideline. The Journal of Clinical Endocrinology & Metabolism 91 (11): 4237 –

4 Criterios de Rooterdam, Mayo 2003 CRITERIOS DE ROOTERDAM (2003) Oligo o anovulación Signos clínicos y/o bioquímicos de hiperandrogenismo Ovarios poliquísticos y exclusión de otras patologías (hiperplasia adrenal congénita, tumores secretores de andrógenos, Síndrome de Cushing) Diagnóstico 2 ó 3 The Rotterdam ESHRE/ASRM – Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long – term health risks related to polycystic ovary syndrome. Fertility and Sterility 81(1) 19 – 25, Jan 2004

5 Criterios de Rooterdam CRITERIOS DE ROOTERDAM (2003) Oligo o anovulación The Rotterdam ESHRE/ASRM – Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long – term health risks related to polycystic ovary syndrome. Fertility and Sterility 81(1) 19 – 25, Jan 2004

6 Oligo o anovulación 75% con alteraciones menstruales 20% eumenorrea Paciente anovulatoria y eumenorreica Progesterona 20 – 24 del ciclo Azziz R., Carmina E., Dewally D., et al., POSITION STATEMENT: Criteria for defining Polycystic Ovary Syndrome as a predominantly hyperandrogenyc syndrome: An Androgen Excess Society Guideline. The Journal of Clinical Endocrinology & Metabolism 91 (11): 4237 –

7 CRITERIOS DE ROOTERDAM (2003) Signos clínicos y/o bioquímicos de hiperandrogenismo The Rotterdam ESHRE/ASRM – Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long – term health risks related to polycystic ovary syndrome. Fertility and Sterility 81(1) 19 – 25, Jan 2004

8 Hiperandrogenismo Hiperandrogenismo Clínico Hirsurtismo Ácne Aloplecia andrógenica The Rotterdam ESHRE/ASRM – Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long – term health risks related to polycystic ovary syndrome. Fertility and Sterility 81(1) 19 – 25, Jan 2004

9 Hiperandrogenismo Hirsurtismo Presente en 60% Escala modificada de Ferriman-Gallwey Azziz R., Carmina E., Dewally D., et al., POSITION STATEMENT: Criteria for defining Polycystic Ovary Syndrome as a predominantly hyperandrogenyc syndrome: An Androgen Excess Society Guideline. The Journal of Clinical Endocrinology & Metabolism 91 (11): 4237 –

10 Hiperandrogenismo Hiperandrogenismo bioquímico (60 – 80%) Medición de testosterona total 6.86 ng/ml Testosterona libre 20 a 40 años: 0.6 – 3.1 pg/mL The Rotterdam ESHRE/ASRM – Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long – term health risks related to polycystic ovary syndrome. Fertility and Sterility 81(1) 19 – 25, Jan 2004

11 Hiperandrogenismo Hiperandrogenismo bioquímico Androstenediona y DHEAS Solo en 10% Azziz R., Carmina E., Dewally D., et al., POSITION STATEMENT: Criteria for defining Polycystic Ovary Syndrome as a predominantly hyperandrogenyc syndrome: An Androgen Excess Society Guideline. The Journal of Clinical Endocrinology & Metabolism 91 (11): 4237 –

12 Hiperandrogenismo Hiperandrogenismo bioquímico Usar solo como auxiliar diagnóstico, NO COMO CRITERIO DIAGNOSTICO AISLADO Azziz R., Carmina E., Dewally D., et al., POSITION STATEMENT: Criteria for defining Polycystic Ovary Syndrome as a predominantly hyperandrogenyc syndrome: An Androgen Excess Society Guideline. The Journal of Clinical Endocrinology & Metabolism 91 (11): 4237 –

13 CRITERIOS DE ROOTERDAM (2003) Ovarios poliquísticos y exclusión de otras patologías (hiperplasia adrenal congénita, tumores secretores de andrógenos, Síndrome de Cushing) The Rotterdam ESHRE/ASRM – Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long – term health risks related to polycystic ovary syndrome. Fertility and Sterility 81(1) 19 – 25, Jan 2004

14 Ovarios Poliquísticos 12 o más folículos en cada ovario de 2 a 9 mm Aumento del volumen de ovario ( >10 mL) The Rotterdam ESHRE/ASRM – Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long – term health risks related to polycystic ovary syndrome. Fertility and Sterility 81(1) 19 – 25, Jan 2004

15 Ovarios Poliquísticos Azziz R., Carmina E., Dewally D., et al., POSITION STATEMENT: Criteria for defining Polycystic Ovary Syndrome as a predominantly hyperandrogenyc syndrome: An Androgen Excess Society Guideline. The Journal of Clinical Endocrinology & Metabolism 91 (11): 4237 –

16 Diagnóstico de SOP Hiperplasia adrenal congénita Síndrome de Cushing Tumores secretores de andrógenos Deficiencia de 21 – hidroxilasa Enfermedades tiroideas Hiperprolactinemia Hipogonadismo hipogonadotrofico Excluir diagnóstico The Rotterdam ESHRE/ASRM – Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long – term health risks related to polycystic ovary syndrome. Fertility and Sterility 81(1) 19 – 25, Jan 2004

17 Clasificación AES 2006 Hiperandrogenismo Hirsurtismo y/o Hiperandrogenemia Disfunción ovárica Oligoovulación Ovario Poliquístico Exclusión de otros trastornos relacionados con el exceso de andrógenos Azziz R., Carmina E., Dewally D., et al., POSITION STATEMENT: Criteria for defining Polycystic Ovary Syndrome as a predominantly hyperandrogenyc syndrome: An Androgen Excess Society Guideline. The Journal of Clinical Endocrinology & Metabolism 91 (11): 4237 –

18 Fenotipos Azziz R., Carmina E., Dewally D., et al., POSITION STATEMENT: Criteria for defining Polycystic Ovary Syndrome as a predominantly hyperandrogenyc syndrome: An Androgen Excess Society Guideline. The Journal of Clinical Endocrinology & Metabolism 91 (11): 4237 –


Descargar ppt "Criterios de Clasificación del Síndrome de Ovario Poliquístico Profesor Titular: Dr. Héctor Godoy Morales Profesor Adjunto: Dr. Alfredo Ulloa Aguirre Presenta:"

Presentaciones similares


Anuncios Google